Clinical Trials Directory

Trials / Completed

CompletedNCT00671749

Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

A Clinical Assessment of Combination Therapy With Differin® Gel, 0.3% With Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
12 Years – 35 Years
Healthy volunteers
Not accepted

Summary

This study is to determine the efficacy and safety of 12 week treatment with Differin® Gel 0.3% applied in the evening, in combination with Duac® (Clindamycin/Benzoyl Peroxide Gel) applied in the morning, in Subjects with Acne vulgaris.

Detailed description

Same as above.

Conditions

Interventions

TypeNameDescription
DRUGadapalene gel, 0.3%Applied once daily at bedtime
DRUGclindamycin/benzoyl peroxide gelApplied once daily in the morning

Timeline

Start date
2007-12-01
Primary completion
2008-08-01
Completion
2008-08-01
First posted
2008-05-05
Last updated
2022-08-23
Results posted
2016-03-16

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00671749. Inclusion in this directory is not an endorsement.